Journal of Diabetes & Metabolism

ISSN - 2155-6156

Citations Report

Journal of Diabetes & Metabolism : Citations & Metrics Report

Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 43, which means every article in Journal of Diabetes & Metabolism has got 43 average citations.

Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.

  2023 2022 2021 2020 2019

Year wise published articles

107 59 61 45 23

Year wise citations received

869 844 899 793 852
Journal total citations count 9622
Journal impact factor 12.50
Journal 5 years impact factor 18.23
Journal cite score 23.62
Journal h-index 43
Journal h-index since 2018 28
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important Citations

Jiménez DL, Temprano RP, Hueso RR, Chozas JM, González JP. Reply to ‘Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes’ by Yoshimoto et al. Journal of Investigative Medicine. 2018 Feb 1;66(2):e4-.

Balakrishnan BB, Krishnasamy K, Mayakrishnan V, Selvaraj A. Moringa concanensis Nimmo extracts ameliorates hyperglycemia-mediated oxidative stress and upregulates PPARγ and GLUT4 gene expression in liver and pancreas of streptozotocin-nicotinamide induced diabetic rats. Biomedicine & Pharmacotherapy. 2019 Apr 1;112:108688.

Bădilă E, Daraban AM, Ţintea E, Bartoş D, Alexandru N, Georgescu A. Midkine proteins in cardio-vascular disease.: Where do we come from and where are we heading to?. European journal of pharmacology. 2015 Sep 5;762:464-71.

Gleeson PJ, Crippa IA, Mongkolpun W, Cavicchi FZ, Van Meerhaeghe T, Brimioulle S, Taccone FS, Vincent JL, Creteur J. Renin as a Marker of Tissue-Perfusion and Prognosis in Critically Ill Patients. Critical care medicine. 2019 Feb 1;47(2):152-8.

Левицкая ЕС, Батюшин ММ, Пасечник ДГ, Асрумян ЭГ. Ремоделирование почечных артерий—инициатор и мишень кардиоренального континуума. Кардиоваскулярная терапия и профилактика. 2015 Nov 25;14(1):90-6.

Zeglinski MR, Moghadam AR, Ande SR, Sheikholeslami K, Mokarram P, Sepehri Z, Rokni H, Mohtaram NK, Poorebrahim M, Masoom A, Toback M. Myocardial cell signaling during the transition to heart failure: cellular signaling and therapeutic approaches. Comprehensive Physiology. 2011 Jan 17;9(1):75-125.

Koszegi S, Molnar A, Lenart L, Hodrea J, Balogh DB, Lakat T, Szkibinszkij E, Hosszu A, Sparding N, Genovese F, Wagner L. RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition. The Journal of physiology. 2019 Jan;597(1):193-209.

Mathes S, van Ginkel S, Vaughan D, Valdivieso P, Flück M. Gene-pharmacologial effects on exercise-induced muscle gene expression in healthy men. Anat. Physiol. S. 2015;5:2161-0940.

Volpe M, Santolamazza C, Tocci G. Hypertension in patients with heart failure with reduced ejection fraction. Current cardiology reports. 2016 Dec 1;18(12):127.

Badila E, Daraban AM, Tintea E, Bartos D, Alexandru N, Georgescu A. Midkine proteins in cardio-vascular disease. Where do we come from and where are we heading to. Eur. J. Pharmacol. 2015 Sep 5;762:464-71.

Bartczak D, Szymański Ł, Bodera P, Stankiewicz W. Psychoneuroimmunological aspects of cardiovascular diseases: a preliminary report. Central-European journal of immunology. 2016;41(2):209.

Nehme A, Zibara K. Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?. Hypertension Research. 2017 Nov;40(11):903.

van der Bel R, Coolen BF, Nederveen AJ, Potters WV, Verberne HJ, Vogt L, Stroes ES, Krediet CP. Magnetic Resonance Imaging–Derived Renal Oxygenation and Perfusion During Continuous, Steady‐State Angiotensin‐II Infusion in Healthy Humans. Journal of the American Heart Association. 2016 Mar 28;5(3):e003185.

Hossain CM, Ghosh MK, Satapathy BS, Dey NS, Mukherjee B. Apigenin causes biochemical modulation, GLUT4 and Cd38 alterations to improve diabetes and to protect damages of some vital organs in experimental diabetes. Am J Pharmacol Toxicol. 2014;9:39-52.

Mora‐Fernández C, Domínguez‐Pimentel V, de Fuentes MM, Górriz JL, Martínez‐Castelao A, Navarro‐González JF. Diabetic kidney disease: from physiology to therapeutics. The Journal of Physiology. 2014 Sep 15;592(18):3997-4012.

Volpe M. Natriuretic peptides and cardio-renal disease. International journal of cardiology. 2014 Oct 20;176(3):630-9.

Uppari DJ. Research and Reviews: Journal of Medical and Health Sciences.

Bhat MA. DAIBETIC NEUROPTHY-A REVIEW.

Alexandrescu VA, Brochier S, Limgba A, Balthazar S, Khelifa H, De Vreese P, Azdad K, Nodit M, Pottier M, Van Espen D, Sinatra T. Healing of Diabetic Neuroischemic Foot Wounds With vs Without Wound-Targeted Revascularization: Preliminary Observations From an 8-Year Prospective Dual-Center Registry. Journal of Endovascular Therapy. 2020:1526602819885131.

Uppari DJ. Research and Reviews: Journal of Medical and Health Sciences.

Top